SpectraCure AB Sustainability Reports
SpectraCure AB is a medical technology company focused on developing advanced systems for the treatment of internal solid cancer tumors. Its proprietary technology platform combines laser light units with specialized software to deliver precise interstitial photodynamic therapy, with an initial clinical focus on prostate cancer.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300U3BMSZ5VGYC283
FIGI: BBG001T91594
11 reports from 2015 to 2025
